Meda E. Pavkov

21.4k total citations · 6 hit papers
113 papers, 11.1k citations indexed

About

Meda E. Pavkov is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Meda E. Pavkov has authored 113 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Nephrology, 46 papers in Endocrinology, Diabetes and Metabolism and 18 papers in Genetics. Recurrent topics in Meda E. Pavkov's work include Chronic Kidney Disease and Diabetes (54 papers), Dialysis and Renal Disease Management (24 papers) and Diabetes Treatment and Management (21 papers). Meda E. Pavkov is often cited by papers focused on Chronic Kidney Disease and Diabetes (54 papers), Dialysis and Renal Disease Management (24 papers) and Diabetes Treatment and Management (21 papers). Meda E. Pavkov collaborates with scholars based in United States, Australia and United Kingdom. Meda E. Pavkov's co-authors include Dianna J. Magliano, Jessica L. Harding, Sarah H. Wild, Christian Bommer, Caroline Stein, William H. Herman, Steven James, Bruce Bartholow Duncan, Edward J. Boyko and Jean Claude Mbanya and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Meda E. Pavkov

102 papers receiving 10.9k citations

Hit Papers

IDF Diabetes Atlas: Global, regional and co... 2016 2026 2019 2022 2021 2018 2018 2016 2019 1000 2.0k 3.0k 4.0k 5.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
    2021 5.7k citations Juliana C.N. Chan, Meda E. Pavkov et al. profile →
  2. Global trends in diabetes complications: a review of current evidence
    2018 1.1k citations Jessica L. Harding, Meda E. Pavkov et al. Diabetologia profile →
  3. The Global Epidemiology of Diabetes and Kidney Disease
    2018 454 citations Digsu N. Koye, Dianna J. Magliano et al. profile →
  4. Trends in Prevalence of Chronic Kidney Disease in the United States
    2016 428 citations Charles E. McCulloch, Meda E. Pavkov et al. profile →
  5. Trends in incidence of total or type 2 diabetes: systematic review
    2019 253 citations Dianna J. Magliano, Rakibul M. Islam et al. profile →
  6. Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years — United States, March 1, 2020–June 28, 2021
    2022 175 citations Alain K. Koyama, Elizabeth A. Lundeen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meda E. Pavkov United States 35 4.5k 2.0k 2.0k 1.6k 1.4k 113 11.1k
Jorge Luiz Gross Brazil 51 5.8k 1.3× 2.3k 1.2× 1.4k 0.7× 1.0k 0.6× 1.5k 1.1× 234 10.5k
Rijk O. B. Gans Netherlands 62 3.8k 0.8× 2.3k 1.2× 3.0k 1.5× 1.5k 0.9× 2.3k 1.7× 358 15.3k
Sophia Zoungas Australia 60 7.2k 1.6× 1.7k 0.8× 2.6k 1.3× 1.6k 1.0× 1.2k 0.9× 290 14.8k
Gregory A. Nichols United States 47 4.2k 0.9× 1.2k 0.6× 1.2k 0.6× 1.3k 0.8× 699 0.5× 150 9.1k
Jaime Uribarri United States 58 5.3k 1.2× 1.9k 1.0× 2.7k 1.4× 891 0.5× 2.9k 2.1× 220 14.3k
Henk J.G. Bilo Netherlands 45 3.4k 0.8× 1.0k 0.5× 1.2k 0.6× 1.0k 0.6× 799 0.6× 246 7.8k
Alicia J. Jenkins Australia 61 5.0k 1.1× 2.8k 1.4× 698 0.4× 1.6k 1.0× 1.7k 1.3× 420 14.4k
Alexandra Kautzky‐Willer Austria 52 3.6k 0.8× 1.7k 0.9× 580 0.3× 1.8k 1.1× 1.8k 1.3× 461 11.3k
Joline W. J. Beulens Netherlands 56 3.1k 0.7× 1.2k 0.6× 780 0.4× 1.6k 1.0× 1.9k 1.4× 305 11.6k
Janet B. McGill United States 64 9.1k 2.0× 2.4k 1.2× 2.2k 1.1× 1.4k 0.8× 1.6k 1.2× 236 16.2k

Countries citing papers authored by Meda E. Pavkov

Since Specialization
Citations

This map shows the geographic impact of Meda E. Pavkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meda E. Pavkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meda E. Pavkov more than expected).

Fields of papers citing papers by Meda E. Pavkov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meda E. Pavkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meda E. Pavkov. The network helps show where Meda E. Pavkov may publish in the future.

Co-authorship network of co-authors of Meda E. Pavkov

This figure shows the co-authorship network connecting the top 25 collaborators of Meda E. Pavkov. A scholar is included among the top collaborators of Meda E. Pavkov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meda E. Pavkov. Meda E. Pavkov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ortíz, Alberto, María José Guerra Palmero, Juliana C.N. Chan, et al.. (2025). Preventing chronic kidney disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International. 108(4). 555–571. 3 indexed citations
2.
Westbrook, Adrianna, Jessica L. Harding, Evan Orenstein, et al.. (2025). Incidence of Leading Causes of Pediatric Chronic Kidney Disease Using Electronic Health Record-Driven Computable Phenotype. Kidney360. 6(7). 1096–1105.
3.
4.
Hoyer, Annika, et al.. (2024). Estimation of mortality rate ratios for chronic conditions with misclassification of disease status at death. BMC Medical Research Methodology. 24(1). 1 indexed citations
5.
Goodrich, Jesse A., Meda E. Pavkov, Daniël H. van Raalte, et al.. (2024). Glycoprotein Acetyls Associate With Intraglomerular Hemodynamic Dysfunction, Albuminuria, Central Adiposity, and Insulin Resistance in Youth With Type 1 Diabetes. Canadian Journal of Diabetes. 48(4). 244–249.e1. 1 indexed citations
6.
Saelee, Ryan, Kai McKeever Bullard, Israel Hora, et al.. (2024). Trends and Inequalities in Diabetes-Related Complications Among U.S. Adults, 2000–2020. Diabetes Care. 48(1). 18–28. 9 indexed citations
7.
Onufrak, Stephen, Ryan Saelee, Ibrahim Zaganjor, et al.. (2024). Prevalence of Self-Reported Diagnosed Diabetes Among Adults, by County Metropolitan Status and Region, United States, 2019–2022. Preventing Chronic Disease. 21. E81–E81.
8.
Magliano, Dianna J., Jedidiah I Morton, Agus Salim, et al.. (2024). Trends in the incidence of young-adult-onset diabetes by diabetes type: a multi-national population-based study from an international diabetes consortium. The Lancet Diabetes & Endocrinology. 12(12). 915–923. 10 indexed citations
9.
Saelee, Ryan, Israel Hora, Meda E. Pavkov, et al.. (2023). Diabetes Prevalence and Incidence Inequality Trends Among U.S. Adults, 2008–2021. American Journal of Preventive Medicine. 65(6). 973–982. 9 indexed citations
10.
Koyama, Alain K., Giuseppina Imperatore, Deborah B. Rolka, et al.. (2023). Risk of Cardiovascular Disease After COVID‐19 Diagnosis Among Adults With and Without Diabetes. Journal of the American Heart Association. 12(13). e029696–e029696. 26 indexed citations
11.
Koyama, Alain K., Kai McKeever Bullard, Stephen Onufrak, et al.. (2023). Risk Factors Amenable to Primary Prevention of Type 2 Diabetes Among Disaggregated Racial and Ethnic Subgroups in the U.S.. Diabetes Care. 46(12). 2112–2119. 6 indexed citations
12.
Zhang, Ping, Jingchuan Guo, Yongkang Zhang, et al.. (2022). Changes in racial and ethnic disparities in glucose‐lowering drug utilization and glycated haemoglobin A1c in US adults with diabetes: 2005‐2018. Diabetes Obesity and Metabolism. 25(2). 516–525. 6 indexed citations
13.
Burrows, Nilka Rı́os, Alain K. Koyama, Devasmita Choudhury, et al.. (2022). Age-Related Association between Multimorbidity and Mortality in US Veterans with Incident Chronic Kidney Disease. American Journal of Nephrology. 53(8-9). 652–662. 6 indexed citations
14.
Bjornstad, Petter, Lily C. Chao, Melanie Cree‐Green, et al.. (2022). Youth-onset type 2 diabetes mellitus: an urgent challenge. Nature Reviews Nephrology. 19(3). 168–184. 58 indexed citations
15.
Chen, Lei, Rakibul M. Islam, Thomas R. Hird, et al.. (2020). A systematic review of trends in all-cause mortality among people with diabetes. Diabetologia. 63(9). 1718–1735. 43 indexed citations
16.
Chen, Zijin, Benjamin J. Lee, Charles E. McCulloch, et al.. (2019). The relation between dialysis-requiring acute kidney injury and recovery from end-stage renal disease: a national study. BMC Nephrology. 20(1). 342–342. 3 indexed citations
17.
McCulloch, Charles E., Chi‐yuan Hsu, Barbara Grimes, et al.. (2017). Colon Cancer Screening among Patients Receiving Dialysis in the United States: Are We Choosing Wisely?. Journal of the American Society of Nephrology. 28(8). 2521–2528. 9 indexed citations
18.
Pavkov, Meda E., E. Jennifer Weil, Gudeta D. Fufaa, et al.. (2015). Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes. Kidney International. 89(1). 226–234. 56 indexed citations
19.
Pavkov, Meda E., William C. Knowler, Robert L. Hanson, et al.. (2013). Comparison of Serum Cystatin C, Serum Creatinine, Measured GFR, and Estimated GFR to Assess the Risk of Kidney Failure in American Indians With Diabetic Nephropathy. American Journal of Kidney Diseases. 62(1). 33–41. 36 indexed citations
20.
Pavkov, Meda E., Peter H. Bennett, Maurice L. Sievers, et al.. (2005). Predominant effect of kidney disease on mortality in Pima Indians with or without type 2 diabetes. Kidney International. 68(3). 1267–1274. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jorge Luiz Gross Breakdown of academic impact, for papers by Rijk O. B. Gans Breakdown of academic impact, for papers by Sophia Zoungas Breakdown of academic impact, for papers by Gregory A. Nichols Breakdown of academic impact, for papers by Jaime Uribarri Breakdown of academic impact, for papers by Henk J.G. Bilo Breakdown of academic impact, for papers by Alicia J. Jenkins Breakdown of academic impact, for papers by Alexandra Kautzky‐Willer Breakdown of academic impact, for papers by Joline W. J. Beulens Breakdown of academic impact, for papers by Janet B. McGill
Rankless by CCL
2026